Search tips
Search criteria 


Logo of brjopthalBritish Journal of OphthalmologyVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Br J Ophthalmol. 1990 June; 74(6): 350–352.
PMCID: PMC1042125

Ocular penetration of cyclosporin A. III: The human eye.


The distribution of cyclosporin A (CsA) in the blood, saliva, tears, aqueous humour, vitreous, and cerebrospinal fluid has been studied after oral treatment with 5 mg/kg/day of CsA or application of 2% CsA eye drops in olive oil solution. After oral treatment all patients had high CsA levels in blood. Measurable levels of CsA were also found in the saliva and tears. Patients without any intraocular inflammation or patients with mild uveitis did not have any detectable CsA in the aqueous humour. However, patients with severe uveitis had significant levels of CsA in the aqueous humour and in the vitreous. No CsA was found in the cerebrospinal fluid of two patients with central nervous system manifestations of Behçet's disease. After local treatment with 2% CsA eye drops no detectable levels of CsA were found in the blood, the saliva, the aqueous humour, or the vitreous even in patients with severe uveitis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (552K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Benezra D, Cohen E. Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol. 1986 Aug;70(8):589–592. [PMC free article] [PubMed]
  • Calne RY, White DJ. The use of cyclosporin A in clinical organ grafting. Ann Surg. 1982 Sep;196(3):330–337. [PubMed]
  • Nussenblatt RB, Rodrigues MM, Salinas-Carmona MC, Gery I, Cevario S, Wacker W. Modulation of experimental autoimmune uveitis with cyclosporin A. Arch Ophthalmol. 1982 Jul;100(7):1146–1149. [PubMed]
  • Nussenblatt RB, Palestine AG, Chan CC. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol. 1983 Sep;96(3):275–282. [PubMed]
  • Graham EM, Sanders MD, James DG, Hamblin A, Kasp Grochowska E, Dumonde D. Cyclosporin A in the treatment of posterior uveitis. Trans Ophthalmol Soc U K. 1985;104(Pt 2):146–151. [PubMed]
  • BenEzra D, Cohen E, Rakotomalala M, de Courten C, Harris W, Chajek T, Friedman G, Matamoros N. Treatment of endogenous uveitis with cyclosporine A. Transplant Proc. 1988 Jun;20(3 Suppl 4):122–127. [PubMed]
  • Svenson K, Bohman SO, Hällgren R. Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine. Arch Intern Med. 1986 Oct;146(10):2007–2010. [PubMed]
  • Palestine AG, Austin HA, 3rd, Balow JE, Antonovych TT, Sabnis SG, Preuss HG, Nussenblatt RB. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med. 1986 May 15;314(20):1293–1298. [PubMed]
  • Bell TA, Hunnisett AG. Cyclosporin A: tissue levels following topical and systemic administration to rabbits. Br J Ophthalmol. 1986 Nov;70(11):852–855. [PMC free article] [PubMed]
  • Wiederholt M, Kössendrup D, Schulz W, Hoffmann F. Pharmacokinetic of topical cyclosporin A in the rabbit eye. Invest Ophthalmol Vis Sci. 1986 Apr;27(4):519–524. [PubMed]
  • Venkataramanan R, Wang CP, Habucky K, Ptachcinski RJ, Burckart GJ, Koneru B, Baker R, Todo S, Starzl TE. Species-specific cyclosporine metabolism. Transplant Proc. 1988 Apr;20(2 Suppl 2):680–683. [PMC free article] [PubMed]
  • Bäckman L, Brandt I, Dallner G, Ringdén O. Tissue distribution of [3H]cyclosporine A in mice. Transplant Proc. 1988 Apr;20(2 Suppl 2):684–691. [PubMed]
  • Palestine AG, Nussenblatt RB, Chan CC. Cyclosporine penetration into the anterior chamber and cerebrospinal fluid. Am J Ophthalmol. 1985 Feb 15;99(2):210–211. [PubMed]
  • Tabbara KF, Gee SS, Alvarez H. Ocular bioavailability of cyclosporine after oral administration. Transplant Proc. 1988 Apr;20(2 Suppl 2):656–659. [PubMed]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group